Paper33568634
Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.
Pani T and 17 others. Cell Death Dis, 2021. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype. Papers, record 33568634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33568634
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alternative Splicing | Major topic |
| Breast Neoplasms | Major topic |
| Cell Movement | Major topic |
| Cell Proliferation | Major topic |
| Ceramides | Major topic |
| Membrane Proteins | Major topic |
| Sphingosine N-Acyltransferase | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Cell Line, Tumor | |
| Databases, Genetic | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Gene Regulatory Networks | |
| Humans | |
| Neoplasm Invasiveness | |
| Signal Transduction | |
| Transcriptome |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29113153 | The role of LASS2 in regulating bladder cancer cell tumorigenicity in a nude mouse model. | Oncol Lett | 2017 | https://conductscience.org/library/papers/29113153 | PubMed |
| 2 | 28824175 | Differential alternative splicing coupled to nonsense-mediated decay of mRNA ensures dietary restriction-induced longevity. | Nat Commun | 2017 | https://conductscience.org/library/papers/28824175 | PubMed |
| 3 | 7069920 | Evaluating the yield of medical tests. | JAMA | 1982 | https://conductscience.org/library/papers/7069920 | PubMed |
| 4 | 19279183 | Ceramide synthases and ceramide levels are increased in breast cancer tissue. | Carcinogenesis | 2009 | https://conductscience.org/library/papers/19279183 | PubMed |
| 5 | 31660434 | A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism. | ACS Cent Sci | 2019 | https://conductscience.org/library/papers/31660434 | PubMed |
| 6 | 21209555 | Dysregulation of sphingolipid metabolism in cancer. | Cancer Biol Ther | 2011 | https://conductscience.org/library/papers/21209555 | PubMed |
| 7 | 29445192 | SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29445192 | PubMed |
| 8 | 12011103 | The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12011103 | PubMed |
| 9 | 22144673 | Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22144673 | PubMed |
| 10 | 22089643 | Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. | J Hum Genet | 2012 | https://conductscience.org/library/papers/22089643 | PubMed |
| 11 | 26887952 | Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26887952 | PubMed |
| 12 | 26787741 | Nonsense-mediated mRNA decay in humans at a glance. | J Cell Sci | 2016 | https://conductscience.org/library/papers/26787741 | PubMed |
| 13 | 28263985 | Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression. | PLoS Genet | 2017 | https://conductscience.org/library/papers/28263985 | PubMed |
| 14 | 29731990 | Ceramide species are elevated in human breast cancer and are associated with less aggressiveness. | Oncotarget | 2018 | https://conductscience.org/library/papers/29731990 | PubMed |
| 15 | 24453046 | Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell. | J Cell Biochem | 2014 | https://conductscience.org/library/papers/24453046 | PubMed |
| 16 | 30149660 | Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30149660 | PubMed |
| 17 | 22248339 | Ceramide synthases at the centre of sphingolipid metabolism and biology. | Biochem J | 2012 | https://conductscience.org/library/papers/22248339 | PubMed |
| 18 | 31748500 | Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31748500 | PubMed |
| 19 | 24632610 | Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility. | Oncogene | 2015 | https://conductscience.org/library/papers/24632610 | PubMed |
| 20 | 18566212 | Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes. | Mol Cancer Ther | 2008 | https://conductscience.org/library/papers/18566212 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42878017 | CerS2-mediated lipotoxicity and calcium signaling: a novel sequential mechanism of apoptosis in cancer. | Biochem J | 2026 | https://conductscience.org/library/papers/42878017 | PubMed |
| 42818130 | Caloric restriction drives age-dependent and integrated remodeling of RNA processing and lipid composition in mouse brain. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818130 | PubMed |
| 42612638 | Targeting of tripartite neuron-cancer-immune cell crosstalk augments response to chemotherapy and immunotherapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42612638 | PubMed |
| 42321779 | Alternative splicing rewires breast cancer and opens therapeutic avenues. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42321779 | PubMed |
| 42012500 | CerS2 Is a Druggable Target in Triple-Negative Breast Cancer. | Mol Cancer Ther | 2026 | https://conductscience.org/library/papers/42012500 | PubMed |
| 41803881 | Sphingolipids in human disease: organ-specific pathologies, chain-length-dependent effects, and translational implications. | J Transl Med | 2026 | https://conductscience.org/library/papers/41803881 | PubMed |
| 41752062 | Aromatase Inhibitor Therapy Is Associated with Distinct Plasma Lipidomic Profiles in Postmenopausal Breast Cancer Patients. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752062 | PubMed |
| 41613787 | Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic Strategies. | Oncol Res | 2026 | https://conductscience.org/library/papers/41613787 | PubMed |
| 40934285 | The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms. | PLoS Biol | 2025 | https://conductscience.org/library/papers/40934285 | PubMed |
| 39885614 | Targeting RNA splicing modulation: new perspectives for anticancer strategy? | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/39885614 | PubMed |
| 39144297 | Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer. | J Thorac Dis | 2024 | https://conductscience.org/library/papers/39144297 | PubMed |
| 38235387 | Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology. | Front Physiol | 2023 | https://conductscience.org/library/papers/38235387 | PubMed |
| 37958652 | The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958652 | PubMed |
| 37885013 | Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer. | Lipids Health Dis | 2023 | https://conductscience.org/library/papers/37885013 | PubMed |
| 37710183 | Acid sphingomyelinase mediates ferroptosis induced by high glucose via autophagic degradation of GPX4 in type 2 diabetic osteoporosis. | Mol Med | 2023 | https://conductscience.org/library/papers/37710183 | PubMed |
| 37390205 | A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response. | Sci Adv | 2023 | https://conductscience.org/library/papers/37390205 | PubMed |
| 37305043 | Association between abnormal lipid metabolism and tumor. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37305043 | PubMed |
| 37092454 | Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype. | Proteomes | 2023 | https://conductscience.org/library/papers/37092454 | PubMed |
| 36768427 | The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768427 | PubMed |
| 36232480 | Emerging Roles of Ceramides in Breast Cancer Biology and Therapy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232480 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33568634
GET https://conductscience.org/api/papers/v1/33568634/references?page=2